Mohamad Mohty

2000–2025 年に発表

482
論文数
48,765
被引用数
126
h 指数
450
i10 指数

被引用数

Mohamad Mohty の年別被引用数1988 年: 被引用 1 件1997 年: 被引用 1 件1999 年: 被引用 1 件2001 年: 被引用 2 件2002 年: 被引用 2 件2003 年: 被引用 23 件2004 年: 被引用 15 件2005 年: 被引用 23 件2006 年: 被引用 13 件2007 年: 被引用 34 件2008 年: 被引用 27 件2009 年: 被引用 52 件2010 年: 被引用 86 件2011 年: 被引用 102 件2012 年: 被引用 106 件2013 年: 被引用 142 件2014 年: 被引用 179 件2015 年: 被引用 189 件2016 年: 被引用 197 件2017 年: 被引用 225 件2018 年: 被引用 207 件2019 年: 被引用 1,265 件2020 年: 被引用 1,872 件2021 年: 被引用 1,974 件2022 年: 被引用 1,733 件2023 年: 被引用 1,381 件2024 年: 被引用 2,807 件2025 年: 被引用 1,190 件2026 年: 被引用 19 件1989〜1996 年は被引用が無いため表示していません1998 年は被引用が無いため表示していません2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,773 件、この内訳の 20.5%ドイツ: 引用元論文 1,403 件、この内訳の 7.6%フランス: 引用元論文 1,276 件、この内訳の 7%イタリア: 引用元論文 1,265 件、この内訳の 6.9%中国: 引用元論文 1,160 件、この内訳の 6.3%イギリス: 引用元論文 1,090 件、この内訳の 5.9%スペイン: 引用元論文 891 件、この内訳の 4.9%オランダ: 引用元論文 667 件、この内訳の 3.6%カナダ: 引用元論文 558 件、この内訳の 3%スイス: 引用元論文 447 件、この内訳の 2.4%日本: 引用元論文 443 件、この内訳の 2.4%オーストラリア: 引用元論文 426 件、この内訳の 2.3%
0%20.5%その他 27.2%

分野

  • Medicine82.7%
  • Biochemistry, Genetics and Molecular Biology7.9%
  • Immunology and Microbiology6.8%
  • Computer Science0.7%
  • Engineering0.2%
  • Health Professions0.2%
  • その他1.5%

トピック

  • Hematopoietic Stem Cell Transplantation9.6%
  • CAR-T cell therapy research6.8%
  • Acute Myeloid Leukemia Research6.3%
  • Multiple Myeloma Research and Treatments5.9%
  • Acute Lymphoblastic Leukemia research3.9%
  • Immune Cell Function and Interaction3.2%
  • その他64.3%

共著者

全論文

検索で開く
  1. Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2023 被引用: 564

  2. A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Roch Houot, Franck Morschhauser - Nature Medicine 2022 被引用: 383

  3. Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

    著者: , , , , , , , , , , , , , - New England Journal of Medicine 2020 被引用: 865

  4. Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , D. Chen, Radovan Vrḫovac, John G. Gribben, Nicolaus Kröger, Hermann Einsele, Ibrahim Yakoub‐Agha - Annals of Oncology 2021 被引用: 422

  5. Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charlotte Graham, Deborah Yallop, Agnieszka Jóźwik, Antonio Pagliuca, Ghulam Mufti, Piers Patten, Shireen Kassam, Stephen Devereux, Majid Kazmi, Kirsty Cuthill, Victoria Potter, Andrea Kühnl, Victoria Metaxa, Laarni Bonganay, Orla Stewart, Rose Ellard, Lorraine Catt, Jen Lewis, Farzin Farzaneh, Jackie Chappell, Alice Mason, Vicky Chu, Alan Dunlop, Adeel Saleem, Gary Cheung, Helena Munro, Elka Giemza, Waseem Qasim, Paul Veys, Oana Ciocârlie, Giovanna Lucchini, Danielle Pinner, Jan Chu, Persis Amrolia, Kanchan Rao, Robert Chiesa, Juliana Silva, Annette Hill, Maria Finch, Lindsey Young, Harvinder Hara, Sujith Samarasinghe, Anupama Rao, Ajay Vora, Anupama Rao, Christine Rivat, Clare Murphy, Gulrukh Ahsan, Rasha Said Shamsah, Jesmina James, Sarah Inglott, Gary Wright, Stuart Adams, Natalia Izotova, Nitin Jain, Marina Konopleva, William G. Wierda, Elias Jabbour, Hagop M. Kantarjian, Partow Kebrieai, Emily Jones, Kara McGee, Marcela V. Maus, Matthew J. Frigault, Jami Brown, Vesselina Toncheva, Keagan S. Casey, Hanno Hock, Meaghan A McKeown, Richard Mathews ほか 40 名 - The Lancet 2020 被引用: 360

  6. LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pieter Sonneveld, Hermann Einsele, Philippe Moreau - Leukemia 2022 被引用: 240

  7. Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kim Kihyun, Gracia Martınez, Min Chang‐Ki, Luděk Pour, Xavier Leleu, Albert Oriol, Koh Youngil, Kenshi Suzuki, Tom Martin, Hang Quach, Andrew Lim, Helen Crowther, Hanlon Sia, Cyrille Hulin, Mohamad Mohty, Gábor Mikala, Zsolt Nagy, Marta Reinoso Segura, Laura Rosiñol, Münci Yağcı, Mehmet Turgut, Mamta Garg, Gurdeep Parmar, Brad Augustson, Nelson Castro, Edvan de Queiroz Crusoé, Tomáš Pika, Sosana Delimpasi, Kenichi Ishizawa, Anup George, Т. С. Константинова, Javier de la Rubia, Kim Sung-Hyun, Ângelo Maiolino, Tony Reiman, Richard LeBlanc, Shigeki Ito, Junji Tanaka, А. С. Лучинин, I. V. Kryuchkova, Joaquín Martínez‐López, Jesse Shustik, Lionel Karlin, Anargyros Symeonidis, Miklós Egyed, Mario Petrini, Michèle Cavo, Michihiro Uchiyama, Hilary Blacklock, Mutlu Arat, James E. Griffin, Hannah Hunter, Tonda Buck, Αchilles Anagnostopoulos, Κωνσταντίνος Κωνσταντόπουλος, Tamás Masszi, Sara Bringhen, Barbara Gamberi, Yawara Kawano, Kim Jin Seok, Hakan Özdoğu, Fahir Özkalemkaş - The Lancet 2021 被引用: 380

  8. Acute lymphoblastic leukaemia

    著者: , - The Lancet 2020 被引用: 735

  9. Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raymond L. Comenzo, Monika Engelhardt, Thomas Illmer, Philip Vlummens, Chantal Doyen, Thierry Façon, Lionel Karlin, Aurore Perrot, Klaus Podar, Michael Kauffman, Sharon Shacham, Lingling Li, Shijie Tang, Carla Picklesimer, Jean‐Richard Saint‐Martin, Marsha Crochiere, Hua Chang, Samir Parekh, Yosef Landesman, Jatin J. Shah, Paul G. Richardson, Sundar Jagannath - New England Journal of Medicine 2019 被引用: 673

  10. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Haematology 2020 被引用: 538

  11. Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022

    著者: , , , , , , , , , , , , , , , , , , , - Bone Marrow Transplantation 2022 被引用: 368

  12. UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vicky Chu, Kirsty Cuthill, Steven Devereux, Alan Dunlop, Rose Ellard, Farzin Farzeneh, Najeem Folarin, Elka Giemza, Shireen Kassam, Majid Kazmi, Andrea Kühnl, Jen Lewis, M.Yu. Liskova, Alice Mason, Victoria Metaxa, Ghulam Mufti, Helena Munro, Antonio Pagliuca, Piers Patten, Victoria Potter, Carmel Rice, Adeel Saleem, Robin Sanderson, Orla Stewart, Elias Jabbour, Nitin Jain, Emily Jones, Hagop M. Kantarjian, Partow Kebriaei, Marina Konopleva, Kara McGee, William G. Wierda, Jami Brown, Keagan S. Casey, Matthew J. Frigault, Hanno Hock, Richard Mathews, Marcela V. Maus, Meaghan A McKeown, Thomas R. Spitzer, Vesselina Toncheva, Élie Azoulay, Nicolas Boissel, Sophie Caillat‐Zucman, Karine Celli‐Lebras, Emmanuelle Clappier, Raphaël Itzykson, Jérôme Larghero, Étienne Lengliné, Isabelle Madelaine, Martine Meunier, Florence Rabian, Emmanuel Raffoux, Marie-Thérèse Tremorin, Agnès Bonnin, Éolia Brissot, Anne Daguenel-Nguyen, Rémy Duléry, Tounes Ledraa, Florent Malard, Clémence Mediavilla, Mohamad Mohty, Anne Vekhoff, Takanori Teshima, Koji Kato - The Lancet Haematology 2022 被引用: 136

  13. Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Haematologica 2019 被引用: 357

  14. Acute graft-versus-host disease

    著者: , , , , - Nature Reviews Disease Primers 2023 被引用: 243

  15. CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies

    著者: , , , , , , , , , , , , , , , , , , - Nature Communications 2022 被引用: 138

  16. Introduction to host microbiome symbiosis in health and disease

    著者: , , , - Mucosal Immunology 2020 被引用: 207

  17. Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tom Willis, Malek Faham, Kenneth C. Anderson, Jean‐Luc Harousseau, Xavier Leleu, Thierry Façon, Philippe Moreau, Michel Attal, Hervé Avet‐Loiseau, Nikhil C. Munshi - Blood 2018 被引用: 420

  18. Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years

    著者: , , , , , , , , , , , , , , , , - Bone Marrow Transplantation 2021 被引用: 428

  19. Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , - Blood 2022 被引用: 148

  20. Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2024 被引用: 243

  21. Multiple myeloma

    著者: , , , , , , , - Nature Reviews Disease Primers 2024 被引用: 257

  22. Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Bone Marrow Transplantation 2019 被引用: 351

  23. Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

    著者: , , , , , , , , , , , , , , , , , , , , , , - The Lancet Haematology 2024 被引用: 222

  24. Nonrelapse mortality after CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Blood Advances 2023 被引用: 77